Total amount raised
$98M
Latest funding date
2025-04-24
Location
Deepcell has successfully raised funds through five venture funding rounds, attracting a total of 11 investors. The company specializes in AI-powered single-cell classification and isolation, catering to various applications in life sciences.
What Is Deepcell?
Deepcell, based in Menlo Park, California, is a life science company specializing in AI-powered single-cell classification and isolation. The company operates in the fields of artificial intelligence, biotechnology, genetics, health care, and life sciences.
With a workforce of 101-250 employees, Deepcell leverages its REM-I platform to integrate imaging, deep learning, and gentle enrichment for single-cell morphology analysis. The company focuses on applications in oncology, drug discovery, cell and gene therapy, and other areas.
How Much Funding Has Deepcell Raised?
- Venture Round (Series Unknown)
- Amount Raised: Not publicly disclosed
- Date: April 24, 2025
- Lead Investors: Fifty Years (50Y VC), represented by D. Scott Phoenix, General Partner
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further develop and expand the company's AI-powered single-cell analysis platform; round open to additional institutional and strategic investors.
- Series B
- Amount Raised: USD 73,000,000
- Date: March 17, 2022
- Lead Investors: Koch Disruptive Technologies (KDT)
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To accelerate the scaling of operations, continue product development, and enable early commercial introduction of Deepcell's AI-powered single-cell analysis platform. New investors included Bridger Healthcare, Horizons Ventures, and Casdin Capital; returning investors included Andreessen Horowitz, Bow Capital, Jeff Dean, and Matt McIlwain.
- Series A
- Amount Raised: USD 20,000,000
- Date: December 7, 2020
- Lead Investors: Bow Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To develop Deepcell's microfluidics-based technology, build a cell morphology atlas, and support commercialization of single-cell analysis. Participants included Andreessen Horowitz, 50Y, DCVC, Stanford University, and angel investor Jeff Dean.
- Seed
- Amount Raised: Not publicly disclosed
- Date: June 2019
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To fund initial research and development efforts.
- Seed
- Amount Raised: USD 5,000,000
- Date: December 2017
- Lead Investors: Andreessen Horowitz
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To establish the company and develop its core single-cell analysis technology.
Total Amount Raised: At least USD 98,000,000 based on disclosed funding (April 2025 venture round amount undisclosed).
Current Valuation: Not publicly disclosed
Key Investors
- Fifty Years (50Y VC)
- Details: Fifty Years is a venture capital firm that invests in companies solving the world's biggest problems. They focus on transformative technologies that can make a significant impact on society. Partner D. Scott Phoenix led the investment in Deepcell's 2025 venture round.
- Investment Focus Areas: Biotechnology, Health Care, Artificial Intelligence
- Notable Investments: Not publicly disclosed
- Koch Disruptive Technologies
- Details: Koch Disruptive Technologies (KDT) is a subsidiary of Koch Industries focused on investing in high-growth companies that are innovating and transforming industries. KDT led Deepcell's $73M Series B in March 2022.
- Investment Focus Areas: Technology, Health Care, Disruptive Innovations
- Notable Investments: Desktop Metal, InSightec, Kinsa
- Bow Capital
- Details: Bow Capital is a venture capital firm that partners with visionary entrepreneurs. They led Deepcell's $20M Series A in December 2020 and participated in the Series B.
- Investment Focus Areas: Technology, Health Care, High-Impact Sectors
- Notable Investments: Fictiv, Vicarious, Rigetti Computing
- Andreessen Horowitz
- Details: Andreessen Horowitz is a private venture capital firm known for its investments in technology companies. They led Deepcell's initial $5M seed round and participated in subsequent rounds including the Series A and Series B.
- Investment Focus Areas: Technology, Health Care, Consumer Internet
- Notable Investments: Facebook, Airbnb, Lyft
- Jeff Dean
- Details: Jeff Dean is the Head of Google Brain, a deep learning artificial intelligence research team at Google. He is renowned for his contributions to AI and deep learning technologies, and participated as an angel investor in Deepcell's Series A and Series B.
- Investment Focus Areas: AI, Deep Learning Technologies
- Notable Investments: Not publicly disclosed
What's Next for Deepcell?
Deepcell stands at the cusp of significant growth, driven by the introduction of its "morpholomics"platform. This AI-powered technology offers unprecedented insights into single-cell morphology, opening doors to advancements in precision medicine, diagnostics, and therapeutic development. The recent $73 million Series B funding round underscores the vast potential of this platform, positioning Deepcell to scale operations and expand its market presence.
As the company transitions to late-stage development, future fundraising opportunities appear promising. The involvement of high-profile investors suggests continued financial support as Deepcell moves towards full commercialization. However, challenges such as ensuring scalability, maintaining cell viability, and navigating a competitive landscape remain. Overcoming these hurdles will be crucial for Deepcell to solidify its position as a leader in single-cell analysis.
Use Clay to Get Funding Data
Sales professionals, take advantage of Clay's platform to access comprehensive fundraising data on companies like Deepcell and gather other critical business insights.
Sign up for free to start leveraging these powerful tools today.
